Cancer pain management in China: current status and practice implications based on the ACHEON survey

por Xia, Zhongjun
Publicado 2017

Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

por Wang, Hua, Li, Pengfei, Zhang, Xinke, Xia, Zhongjun, Lu, Yue, Huang, Huiqiang
Publicado 2016

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients

por Wang, Hua, Wang, Liang, Lu, Yue, Chen, Xiaoqin, Geng, Qirong, Wang, Weida, Xia, Zhongjun
Publicado 2016

A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience

por Li, Chun, Wuxiao, Zhi-Jun, Chen, Xiaoqin, Chen, Guanjun, Lu, Yue, Xia, Zhongjun, Liang, Yang, Wang, Hua
Publicado 2020

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study

por Fan, Huishou, Wang, Weida, Zhang, Ya, Wang, Jianxiang, Cheng, Tao, Qiu, Lugui, Wang, Xin, Xia, Zhongjun, An, Gang
Publicado 2023

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World...

por Shang, Yufeng, Wang, Weida, Liang, Yuxing, Kaweme, Natasha Mupeta, Wang, Qian, Liu, Minghui, Chen, Xiaoqin, Xia, Zhongjun, Zhou, Fuling
Publicado 2022

Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma

por Su, Ning, Fang, Yu, Chen, Xu, Chen, Xiaoqin, Xia, Zhongjun, Huang, Huiqiang, Xia, Yi, Liu, Panpan, Tian, Xiaopeng, Cai, Qingqing
Publicado 2023

Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study

por Wang, Kefeng, Yang, Hang, He, Wenjun, Xia, Yi, Xia, Zhongjun, Li, Su, Huang, Huiqiang, Li, Zhiming, Liu, Panpan, Jiang, Wenqi
Publicado 2017

High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma

por Guo, Xiaofang, Wang, Juan, Jin, Jietian, Chen, Hao, Zhen, Zijun, Jiang, Wenqi, Lin, Tongyu, Huang, Huiqiang, Xia, Zhongjun, Sun, Xiaofei
Publicado 2018

Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming

por Liang, Yuanzheng, He, Haiyan, Wang, Weida, Wang, Henan, Mo, Shaowen, Fu, Ruiying, Liu, Xindi, Song, Qiong, Xia, Zhongjun, Wang, Liang
Publicado 2022

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy

por Wang, Hua, Wang, Liang, Wuxiao, ZhiJun, Huang, HuiQiang, Jiang, WenQi, Li, ZhiMing, Lu, Yue, Xia, ZhongJun
Publicado 2015

Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma

por Zhong, Weijie, Xu, Xin, Zhu, Zhigang, Yang, Li, Du, Hong, Xia, Zhongjun, Yuan, Zhaohu, Xiong, Huabao, Du, Qinghua, Wei, Yaming, Li, Qingshan
Publicado 2018

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA du...

por Cai, Qingqing, Chen, Kailin, Chen, Jie, Wu, Shaoxu, Geng, Qirong, Huang, Huiqiang, Lin, Tongyu, Jiang, Wenqi, Xia, Zhongjun, Duan, Huaxin, Rao, Huilan, Yao, Mengfei, Hu, Liyang
Publicado 2016

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

por Huang, JiaJia, Jiang, WenQi, Xu, RuiHua, Huang, HuiQiang, Lv, Yue, Xia, ZhongJun, Sun, XiaoFei, Guan, ZhongZhen, Lin, TongYu, Li, ZhiMing
Publicado 2010

P925: PHASE 1 TRIAL OF ANTI-CD38 MONOCLONAL ANTIBODY CM313 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OR LYMPHOMA

por Chen, Wenming, Huang, Zhongxia, Fang, Baijun, Song, Yuqin, Jing, Hongmei, Xia, Zhongjun, Cai, Zhen, An, Gang, Zhou, Huixing, Liu, Nian, LI, Xin, Liu, Yuzhang, Ping, Lingyan, Wan, Wei, Chen, Xiaoqin, He, Jingsong, Xu, Yan
Publicado 2023

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

por Zhou, Qian, Liang, Jinxia, Yang, Tong, Liu, Jin, Li, Bo, Li, Yingchang, Fan, Zhenzhen, Wang, Weida, Chen, Wensheng, Yuan, Sujing, Xu, Meng, Xu, Qigui, Luan, Zhidong, Xia, Zhongjun, Zhou, Penghui, Huang, Yadong, Chen, Liang
Publicado 2021

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

por Sun, Yan, Cheng, Ying, Hao, Xuezhi, Wang, Jie, Hu, Chengping, Han, Baohui, Liu, Xiaoqing, Zhang, Li, Wan, Huiping, Xia, Zhongjun, Liu, Yunpeng, Li, Wei, Hou, Mei, Zhang, Helong, Xiu, Qingyu, Zhu, Yunzhong, Feng, Jifeng, Qin, Shukui, Luo, Xiaoyan
Publicado 2016

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinic...

por Li, Jing, Bao, Li, Xia, Zhongjun, Wang, Sili, Zhou, Xin, Ding, Kaiyang, Zhang, Wenhao, Yang, Wei, Li, Bingzong, Fu, Chengcheng, Chen, Bing, Hua, Luoming, Wang, Liang, Luo, Jun, Yang, Yang, Xu, Tianhong, Wang, Weida, Huang, Yun, Wu, Guolin, Liu, Peng
Publicado 2020

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study

por Zhang, Yuchen, Ma, Shuyun, Cai, Jun, Yang, Yu, Jing, Hongmei, Shuang, Yuerong, Peng, Zhigang, Li, Bingzong, Liu, Panpan, Xia, Zhongjun, Xia, Yi, Gao, Yan, Chen, Daoguang, Lin, Jianyang, Li, Qihui, Xu, Shenghua, Xu, Qingyuan, Zhang, Han, Huang, Huiqiang, Cai, Qingqing
Publicado 2021

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MA...

por Qiu, Lugui, Xia, Zhongjun, Fu, Chengcheng, Chen, Wenming, Chang, Chunkang, Fang, Baijun, An, Gang, Wei, Yongqiang, Cai, Zhen, Gao, Sujun, Weng, Jianyu, Chen, Lijuan, Jing, Hongmei, Li, Fei, Liu, Zhuogang, Chen, Xiequn, Liu, Jing, Wang, Aihua, Yu, Yang, Xiang, Wenxi, Lynch, Kevin, Yu, Zhinuan, Fu, Weijun
Publicado 2022